Dr. Charles Weaver is a Medical Oncologist, and the founder and editor of CancerConnect. After training at University of Pennsylvania, Fred Hutchinson Cancer Center and The National Institute of Health Dr Weaver founded CancerConnect with the goal of providing information and support to cancer patien...
Conclusion Although I-125 plaque brachytherapy has become the treatment of choice for medium-sized choroidal melanoma, there are numerous post-treatment complications of relevance to the ocular oncologist and referring ophthalmologist. Anterior segment pathology occurs in 4–23% of treated patients with ...
Oncologist. Oct. 2007;12(10):1237-46. Chiu et al., siRNA function in RNAi: a chemical modification analysis. RNA. Sep. 2003;9(9):1034-48. Choi et al., Control of scarring in adult wounds using antisense transforming growth factor-beta 1 oligodeoxynucleotides. Immunol Cell Biol. Apr...
For this high-risk population, recommendations made by the American Association of Ophthalmic Oncologists and Pathologists and endorsed by the AAPOS and AAP include serial dilated fundus examinations with or without anesthesia from birth until 7 years of age, with intervals dictated by risk [30]. ...